Nguyen, Binh An
Singh, Virender http://orcid.org/0000-0002-6720-8784
Afrin, Shumaila
Yakubovska, Anna
Wang, Lanie
Ahmed, Yasmin
Pedretti, Rose
Fernandez-Ramirez, Maria del Carmen
Singh, Preeti http://orcid.org/0000-0003-2508-5613
Pękała, Maja
Cabrera Hernandez, Luis O. http://orcid.org/0000-0003-4986-6529
Kumar, Siddharth
Lemoff, Andrew http://orcid.org/0000-0002-4943-0170
Gonzalez-Prieto, Roman http://orcid.org/0000-0001-8997-2321
Sawaya, Michael R. http://orcid.org/0000-0003-0874-9043
Eisenberg, David S. http://orcid.org/0000-0003-2432-5419
Benson, Merrill Douglas
Saelices, Lorena http://orcid.org/0000-0002-1904-2150
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (DP2-HL163810)
American Heart Association (847236)
Welch Foundation (I-2121-20220331)
Article History
Received: 5 July 2023
Accepted: 4 January 2024
First Online: 17 January 2024
Competing interests
: L.S. consults for Intellia Therapeutics Inc. and Attralus Inc., and Advisory Board member for Alexion Pharmaceuticals. The remaining authors declare no competing interests.